Samlyn Capital, LLC Acadia Pharmaceuticals Inc Transaction History

Samlyn Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $15.3 Million - $21.6 Million	-789,061 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $4.9 Million - $10.8 Million	195,896 Added 33.03%	789,061 $20.4 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $3.57 Million - $4.94 Million	-87,029 Reduced 12.79%	593,165 $31.7 Million
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $24.8 Million - $38.8 Million	680,194 New	680,194 $28.1 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.71B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.